NO20021251L - Tienoisoksazolyl- og tienylpyrrazolyl-fenoksysubstituerte propylderivater anvendbare som D4antagonister - Google Patents
Tienoisoksazolyl- og tienylpyrrazolyl-fenoksysubstituerte propylderivater anvendbare som D4antagonisterInfo
- Publication number
- NO20021251L NO20021251L NO20021251A NO20021251A NO20021251L NO 20021251 L NO20021251 L NO 20021251L NO 20021251 A NO20021251 A NO 20021251A NO 20021251 A NO20021251 A NO 20021251A NO 20021251 L NO20021251 L NO 20021251L
- Authority
- NO
- Norway
- Prior art keywords
- thienylpyrrazolyl
- antagonists
- compounds
- tienoisoxazolyl
- substituted propyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39608199A | 1999-09-14 | 1999-09-14 | |
PCT/US2000/024962 WO2001019833A1 (en) | 1999-09-14 | 2000-09-13 | Thienoisoxazolyl- and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as d4 antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20021251D0 NO20021251D0 (no) | 2002-03-13 |
NO20021251L true NO20021251L (no) | 2002-05-10 |
Family
ID=23565772
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20021251A NO20021251L (no) | 1999-09-14 | 2002-03-13 | Tienoisoksazolyl- og tienylpyrrazolyl-fenoksysubstituerte propylderivater anvendbare som D4antagonister |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP1216250B1 (hu) |
JP (1) | JP4847662B2 (hu) |
KR (1) | KR20020027647A (hu) |
AR (1) | AR032134A1 (hu) |
AT (1) | ATE254621T1 (hu) |
AU (1) | AU7577400A (hu) |
BR (1) | BR0014515A (hu) |
CA (1) | CA2383340C (hu) |
CY (1) | CY1101692T1 (hu) |
CZ (1) | CZ2002897A3 (hu) |
DE (1) | DE60006699T2 (hu) |
DK (1) | DK1216250T3 (hu) |
EA (1) | EA200200355A1 (hu) |
EE (1) | EE200200135A (hu) |
ES (1) | ES2209995T3 (hu) |
HR (1) | HRP20020220A2 (hu) |
HU (1) | HUP0203526A3 (hu) |
IL (1) | IL148623A0 (hu) |
MX (1) | MXPA02002695A (hu) |
NO (1) | NO20021251L (hu) |
PL (1) | PL354515A1 (hu) |
PT (1) | PT1216250E (hu) |
SK (1) | SK3512002A3 (hu) |
TW (1) | TW530060B (hu) |
WO (1) | WO2001019833A1 (hu) |
ZA (1) | ZA200201762B (hu) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7253165B2 (en) | 1999-09-14 | 2007-08-07 | Aventis Pharmaceuticals Inc. | Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists |
US7091199B1 (en) | 1999-09-14 | 2006-08-15 | Aventis Pharmaceuticals Inc. | Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists |
US7125903B1 (en) | 1999-09-14 | 2006-10-24 | Aventis Pharmaceuticals Inc. | Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists |
EP1688412A3 (en) * | 2001-02-16 | 2006-08-16 | Aventis Pharmaceuticals, Inc. | Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
CN1300116C (zh) | 2001-04-16 | 2007-02-14 | 卫材株式会社 | 1h-吲唑化合物 |
KR20040020457A (ko) * | 2002-08-30 | 2004-03-09 | 주식회사 대웅 | 3-{2-[4-(6-플루오로벤조[d]이속사졸-3-일)피페리디노]에틸}-2-메틸-6,7,8,9-테트라하이드로-4H-피리도[1,2-a]피리미딘-4-온 또는 그 산부가염의 제조방법 |
AU2004209522A1 (en) * | 2003-01-17 | 2004-08-19 | Gilead Palo Alto, Inc. | Substituted heterocyclic compounds useful in the treatment of cardiovascular diseases |
JP2007297321A (ja) * | 2006-04-28 | 2007-11-15 | Daiso Co Ltd | アリール2−メチルグリシジルエーテル類の製造法 |
JP2007297330A (ja) * | 2006-04-28 | 2007-11-15 | Daiso Co Ltd | 2−メチルグリシジル誘導体の製造法 |
US9604930B2 (en) | 2012-12-21 | 2017-03-28 | Epizyme, Inc. | Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereof |
CA2894157A1 (en) | 2012-12-21 | 2014-06-26 | Epizyme, Inc. | Prmt5 inhibitors and uses thereof |
US8940726B2 (en) | 2012-12-21 | 2015-01-27 | Epizyme, Inc. | PRMT5 inhibitors and uses thereof |
WO2014100716A1 (en) | 2012-12-21 | 2014-06-26 | Epizyme, Inc. | Prmt5 inhibitors and uses thereof |
CA2894126A1 (en) * | 2012-12-21 | 2014-06-26 | Epizyme, Inc. | Prmt5 inhibitors and uses thereof |
WO2015200680A2 (en) * | 2014-06-25 | 2015-12-30 | Epizyme, Inc. | Prmt5 inhibitors and uses thereof |
AU2015301196A1 (en) | 2014-08-04 | 2017-01-12 | Epizyme, Inc. | PRMT5 inhibitors and uses thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4728651A (en) * | 1985-10-24 | 1988-03-01 | Hoechst-Roussel Pharmaceuticals Inc. | Antihypertensive thieno-isoxazoles and -pyrazoles |
US6187774B1 (en) * | 1996-03-04 | 2001-02-13 | Yoshitomi Pharmaceutical Industries, Ltd. | Fused heterocyclic compounds and pharmaceutical applications thereof |
HUP9603001A3 (en) * | 1996-10-30 | 1999-07-28 | Richter Gedeon Vegyeszet | Heterocycle compounds comprising nitrogen, process for producing them and pharmaceutical compositions containing the same |
DE69936572T2 (de) * | 1998-02-09 | 2008-06-19 | Duphar International Research B.V. | Benzisoxazolderivate mit d4-antagonistischer wirkung |
-
2000
- 2000-09-13 AR ARP000104793A patent/AR032134A1/es not_active Application Discontinuation
- 2000-09-13 CA CA2383340A patent/CA2383340C/en not_active Expired - Fee Related
- 2000-09-13 EE EEP200200135A patent/EE200200135A/xx unknown
- 2000-09-13 IL IL14862300A patent/IL148623A0/xx unknown
- 2000-09-13 CZ CZ2002897A patent/CZ2002897A3/cs unknown
- 2000-09-13 PT PT00964969T patent/PT1216250E/pt unknown
- 2000-09-13 JP JP2001523410A patent/JP4847662B2/ja not_active Expired - Fee Related
- 2000-09-13 AU AU75774/00A patent/AU7577400A/en not_active Abandoned
- 2000-09-13 EP EP00964969A patent/EP1216250B1/en not_active Expired - Lifetime
- 2000-09-13 EA EA200200355A patent/EA200200355A1/ru unknown
- 2000-09-13 MX MXPA02002695A patent/MXPA02002695A/es active IP Right Grant
- 2000-09-13 KR KR1020027003366A patent/KR20020027647A/ko not_active Application Discontinuation
- 2000-09-13 BR BR0014515-7A patent/BR0014515A/pt not_active IP Right Cessation
- 2000-09-13 HU HU0203526A patent/HUP0203526A3/hu unknown
- 2000-09-13 ES ES00964969T patent/ES2209995T3/es not_active Expired - Lifetime
- 2000-09-13 DK DK00964969T patent/DK1216250T3/da active
- 2000-09-13 AT AT00964969T patent/ATE254621T1/de not_active IP Right Cessation
- 2000-09-13 SK SK351-2002A patent/SK3512002A3/sk unknown
- 2000-09-13 PL PL00354515A patent/PL354515A1/xx unknown
- 2000-09-13 DE DE60006699T patent/DE60006699T2/de not_active Expired - Lifetime
- 2000-09-13 WO PCT/US2000/024962 patent/WO2001019833A1/en not_active Application Discontinuation
- 2000-09-14 TW TW089118850A patent/TW530060B/zh not_active IP Right Cessation
-
2002
- 2002-03-12 HR HR20020220A patent/HRP20020220A2/hr not_active Application Discontinuation
- 2002-03-13 NO NO20021251A patent/NO20021251L/no not_active Application Discontinuation
- 2002-03-21 ZA ZA200201762A patent/ZA200201762B/en unknown
-
2004
- 2004-02-12 CY CY20041100175T patent/CY1101692T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK1216250T3 (da) | 2004-02-23 |
PT1216250E (pt) | 2004-04-30 |
DE60006699D1 (en) | 2003-12-24 |
HRP20020220A2 (en) | 2004-02-29 |
ZA200201762B (en) | 2003-08-27 |
PL354515A1 (en) | 2004-01-26 |
TW530060B (en) | 2003-05-01 |
HUP0203526A2 (hu) | 2003-01-28 |
HUP0203526A3 (en) | 2004-12-28 |
AU7577400A (en) | 2001-04-17 |
JP2003509432A (ja) | 2003-03-11 |
CY1101692T1 (el) | 2010-07-28 |
KR20020027647A (ko) | 2002-04-13 |
MXPA02002695A (es) | 2002-07-30 |
EP1216250A1 (en) | 2002-06-26 |
EA200200355A1 (ru) | 2002-10-31 |
CZ2002897A3 (cs) | 2002-07-17 |
NO20021251D0 (no) | 2002-03-13 |
ES2209995T3 (es) | 2004-07-01 |
WO2001019833A1 (en) | 2001-03-22 |
JP4847662B2 (ja) | 2011-12-28 |
CA2383340A1 (en) | 2001-03-22 |
CA2383340C (en) | 2010-06-15 |
EP1216250B1 (en) | 2003-11-19 |
IL148623A0 (en) | 2002-09-12 |
SK3512002A3 (en) | 2003-03-04 |
EE200200135A (et) | 2003-04-15 |
ATE254621T1 (de) | 2003-12-15 |
BR0014515A (pt) | 2002-06-25 |
AR032134A1 (es) | 2003-10-29 |
DE60006699T2 (de) | 2004-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20021251L (no) | Tienoisoksazolyl- og tienylpyrrazolyl-fenoksysubstituerte propylderivater anvendbare som D4antagonister | |
WO2008156713A3 (en) | Anti-cd20 therapeutic compositions and methods | |
WO2006073973A3 (en) | Novel benzylamine derivatives as cetp inhibitors | |
WO2007014238A3 (en) | Single dose use of cd20-specific binding molecules | |
MY150088A (en) | Immunosuppressant compounds and compositions | |
WO2006064453A3 (en) | Targeting agents for molecular imaging | |
WO2005019179A3 (en) | Benzazepine derivatives useful for the treatment of 5ht2c receptor associated diseases | |
WO2005046603A3 (en) | Pyridine compounds | |
CL2008001960A1 (es) | Compuestos derivados de tetrahidropiranocromano, procedimiento de preparacion, composicion farmaceutica, util para inhibir gamma-secretasa, destinados al tratamiento de enfermedades neurodegenetarivas, enfermedad de alzheimer e inhibir el deposito de proteina amiloide. | |
WO2004009062A3 (en) | NMDA RECEPTOR ANTAGONISTS AND THEIR USE IN INHIBITING ABNORMAL HYPERPHOSPHORYLATION OF MICROTUBULE ASSOCIATED PROTEIN tau | |
WO2005085188A3 (en) | Compounds and methods for anti-tumor therapy | |
WO2007109799A3 (en) | Polymorphs of eszopiclone malate | |
WO2004106322A3 (en) | Polymorphs of aripiprazole | |
WO2006042137A3 (en) | Methods for identifying parkinson's disease therapeutics | |
WO2005092062A3 (en) | Compounds for neurodegenerative disorders | |
HK1104280A1 (en) | Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseases | |
DE60004543D1 (de) | Benzisoxazolyl-, pyridoisoxazolyl- und benzthienyl-phenoxy derivate als d4 antagonisten | |
WO2005054172A3 (en) | Jasmonate derivative compounds, pharmaceuticals compositions and methods of use thereof | |
WO2010000089A8 (en) | Stat3 and tyk2 as drug targets for neurodegenerative diseases | |
GB0504103D0 (en) | Novel method | |
WO2001019832A3 (en) | Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists | |
WO2008058278A3 (en) | POLYMORPHS OF N2-(1, 1' - BIPHENYL - 4 - YLCARBONYL) - N1- [2- (4 - FLUOROPHENYL) -1, 1 - DIMETHYLETHYL]- L - α -GLUTAMINE | |
WO2007063428A3 (en) | Pharmaceutical compositions comprising carboxyalkylsulfonic acids | |
UA87292C2 (ru) | Применение сирамезина для лечения злокачественных опухолей | |
WO2007079198A3 (en) | Metaxalone formulations and methods for the preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |